Pathology & Lab Medicine News

  • AAO Stem Cell Therapy Shows Promise for Retinal Degeneration Retinal pigment epithelial cells derived from human embryonic stem cells can be safely transplanted into the eyes of patients with retinal degeneration, with early signs of vision gain.
 
  • MMR/MSI Testing in Colorectal Cancer 'Alarmingly' Low Testing for mismatch repair (MMR) deficiency is suboptimal despite endorsement and well-established guidelines. Will that change now that immunotherapy is approved?
  • Liquid Gold: Screening Urine for Drugs The cups of urine travel by express mail to the Comprehensive Pain Specialists lab in an industrial park in Brentwood, Tenn., not far from Nashville. Most days bring more than 700 of the little sealed cups from clinics across 10 states.
 

Today on Medscape

Top Stories from Across Medicine

Top Medical News from Across Medscape

  • Brain Imaging Identifies CTE in a Living PersonA PET scan using a tau tracer accurately diagnosed chronic traumatic encephalopathy in a living professional football player, a finding researchers describe as a diagnostic 'milestone.'
  • Thrombectomy Up to 24 Hours Effective in Certain StrokesPublished results of the DAWN trial show patients with salvageable brain tissue identified by 'clinical-core mismatch' benefitted from endovascular therapy up to 24 hours after onset.
  • Whistleblowing Neurosurgeon Wins Big, but at a PriceA neurosurgeon convinced a judge that he was fired for reporting a colleague whose license was later suspended for disruptive behavior. The victor's $17.5 million court award, though, comes at a price.

Perspective

Business of Medicine

Columnists

Advisory Board

 

Site Editorial Director

Medscape Editor-in-Chief

  • Eric J. Topol, MD Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape
также читайте